enVVeno Medical (NVNO) Liabilities and Shareholders Equity (2017 - 2026)

enVVeno Medical's Liabilities and Shareholders Equity history runs 10 years deep, the most recent figure standing at $26.1 million for Q1 2026.

• In Q1 2026, Liabilities and Shareholders Equity fell 35.69% year-over-year to $26.1 million; the TTM figure through Mar 2026 stood at $124.6 million (down 29.58% YoY), while the FY2025 annual figure was $29.6 million, down 34.24% from the prior year.
• Liabilities and Shareholders Equity was $26.1 million for Q1 2026 at enVVeno Medical, down from $29.6 million in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $54.2 million in Q1 2022 to a low of $26.1 million in Q1 2026.
• Historically, Liabilities and Shareholders Equity has averaged $40.2 million across 5 years, with a median of $41.0 million in 2024.
• The sharpest annual moves came in 2023 and 2024: Liabilities and Shareholders Equity sank 38.2% in 2023, then jumped 79.36% in 2024.
• A 5-year view of Liabilities and Shareholders Equity shows it stood at $41.7 million in 2022, then increased by 16.74% to $48.6 million in 2023, then decreased by 7.57% to $45.0 million in 2024, then tumbled by 34.24% to $29.6 million in 2025, then fell by 11.72% to $26.1 million in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $26.1 million (Q1 2026), $29.6 million (Q4 2025), and $32.4 million (Q3 2025), per Business Quant data.